Ann Marie Mauer to Receptor Protein-Tyrosine Kinases
This is a "connection" page, showing publications Ann Marie Mauer has written about Receptor Protein-Tyrosine Kinases.
Connection Strength
0.058
-
Phase I clinical trial of CEP-2563 dihydrochloride, a receptor tyrosine kinase inhibitor, in patients with refractory solid tumors. Invest New Drugs. 2004 Nov; 22(4):449-58.
Score: 0.058
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.